Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2018
Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary interventionIsabel Wustrow, Nikolaus Sarafoff, Bernhard Haller, et al.
Circulation. Cardiovascular Interventions|February 3, 2012
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stentingJuliane Jaitner, Tanja Morath, Robert A Byrne, et al.
Platelets|January 18, 2014
Predictors of antiplatelet response to prasugrel during maintenance treatmentKatharina Mayer, Martin Orban, Isabell Bernlochner, et al.
Journal of the American College of Cardiology|May 16, 2015
Reply: Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI RegistryKatharina Mayer, Isabell Bernlochner, Siegmund Braun, et al.
Journal of the American College of Cardiology|August 30, 2014
Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registryKatharina Mayer, Isabell Bernlochner, Siegmund Braun, et al.
Thrombosis and Haemostasis|September 21, 2018
Platelet Reactivity and Early Outcomes after Transfemoral Aortic Valve ImplantationLisa Gross, David Jochheim, Tobias Nitschke, et al.
Platelets|March 1, 2012
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrelIsabell Bernlochner, Tanja Morath, Patricia B Brown, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2019
Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trialRalph Hein, Lisa Gross, Dániel Aradi, et al.
Platelets|March 5, 2016
Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivityLisa Gross, Dirk Sibbing, Madeleine Eickhoff, et al.
Thrombosis and Haemostasis|August 14, 2018
Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping SubstudyLisa Gross, Dietmar Trenk, Claudius Jacobshagen, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2018
Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary interventionIsabel Wustrow, Nikolaus Sarafoff, Bernhard Haller, et al.
Circulation. Cardiovascular Interventions|February 3, 2012
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stentingJuliane Jaitner, Tanja Morath, Robert A Byrne, et al.
Platelets|January 18, 2014
Predictors of antiplatelet response to prasugrel during maintenance treatmentKatharina Mayer, Martin Orban, Isabell Bernlochner, et al.
Journal of the American College of Cardiology|May 16, 2015
Reply: Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI RegistryKatharina Mayer, Isabell Bernlochner, Siegmund Braun, et al.
Journal of the American College of Cardiology|August 30, 2014
Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registryKatharina Mayer, Isabell Bernlochner, Siegmund Braun, et al.
Thrombosis and Haemostasis|September 21, 2018
Platelet Reactivity and Early Outcomes after Transfemoral Aortic Valve ImplantationLisa Gross, David Jochheim, Tobias Nitschke, et al.
Platelets|March 1, 2012
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrelIsabell Bernlochner, Tanja Morath, Patricia B Brown, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2019
Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trialRalph Hein, Lisa Gross, Dániel Aradi, et al.
Platelets|March 5, 2016
Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivityLisa Gross, Dirk Sibbing, Madeleine Eickhoff, et al.
Thrombosis and Haemostasis|August 14, 2018
Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping SubstudyLisa Gross, Dietmar Trenk, Claudius Jacobshagen, et al.
Pageof 20